Hint mode is switched on Switch off

HELX - Franklin Genomic Advancements ETF (USD) (US35473P5200)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Choose all Reset all
 
(%)
US35473P5200
HELX ISIN
Exchange Traded Funds (ETF)
Type of fund
Franklin Templeton Investments
Provider
35.73 USD
NAV per Share | 04/06/2026
25/02/2020
Inception Date
1 times per year
Dividend payments
CEOJLS
CFI
HELX
Ticker
Formed
Status
Equity
Investment category
Biotech
Sector
USA
Investor locations
Russell 3000 Index
Benchmark
0.5 %
Total Cost Ratio
23.22 mln USD
Fund NAV | 04/06/2026
23.22 mln USD
Share Class NAV | 04/06/2026
No
UCITS

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Yield on 04/06/2026, Cboe BZX Exchange

  • YTD
    -10.83 %
  • 1M
    -6.62 %
  • 3M
    -7.6 %
  • 6M
    -7.55 %
  • 1Y
    24.21 %
  • 3Y
    9 %
  • 5Y
    -21.11 %
  • 10Y
    -
At the price on the exchange, taking into account income payments

Latest data on
Add to compare
from
to
ADD-IN
Cbonds add-in API
bond data api

Quotes (HELX)

Explore the most comprehensive database

1 000 000

bonds

80 234

stocks

167 970

ETF & Funds

70 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Price dynamics

HELX profile

The Franklin Genomic Advancements ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The Franklin Templeton Investments fund’s base currency is USD and the share class was registered 25.02.2020 with unique ISIN - US35473P5200. Main exchange is Cboe BZX Exchange and ticker symbol is HELX. The total expense ratio is 0.5%. The Franklin Genomic Advancements ETF (USD) pays dividends 1 time(s) per year.

Structure HELX on 04/06/2026

Download structure in Excel
Paper Value
GUARDANT HEALTH INC GH 9.01%
NATERA INC NTRA 6.82%
KRYSTAL BIOTECH INC KRYS 5.86%
UNITED THERAPEUTICS CORP UTHR 3.96%
LIGAND PHARMACEUTICALS LGND 3.85%
ADAPTIVE BIOTECHNOLOGIES ADPT 3.76%
BRIDGEBIO PHARMA INC BBIO 3.53%
ELI LILLY & CO LLY 3.1%
ASTRAZENECA PLC AZN 2.89%
VERTEX PHARMACEUTICALS IN VRTX 2.73%
INSMED INC INSM 2.68%
SAMSUNG BIOLOGICS CO LTD 207940 2.48%
CORTEVA INC CTVA 2.3%
TWIST BIOSCIENCE CORP TWST 2.29%
ALNYLAM PHARMACEUTICALS I ALNY 2.21%
CASH — 2.21%
TRAVERE THERAPEUTICS INC TVTX 2.14%
MEDPACE HOLDINGS INC MEDP 2.08%
NEUROCRINE BIOSCIENCES IN NBIX 2.05%
REGENERON PHARMACEUTICALS REGN 2.03%
IONIS PHARMACEUTICALS INC IONS 2.02%
TEMPUS AI INC-CL A TEM 1.96%
ARGENX SE ARGX 1.68%
VERACYTE INC VCYT 1.56%
BIONTECH SE-ADR BNTX 1.49%
PTC THERAPEUTICS INC PTCT 1.42%
STOKE THERAPEUTICS INC STOK 1.37%
GRAIL INC GRAL 1.19%
CADENCE DESIGN SYS INC CDNS 1.19%
CHARLES RIVER LABORATORIE CRL 1.16%
CRISPR THERAPEUTICS AG CRSP 1.15%
SARTORIUS AG-VORZUG SRT3 1.05%
REPLIGEN CORP RGEN 1.02%
BEAM THERAPEUTICS INC BEAM 0.99%
ANAPTYSBIO INC ANAB 0.89%
JAZZ PHARMACEUTICALS PLC JAZZ 0.87%
AXSOME THERAPEUTICS INC AXSM 0.87%
CATALYST PHARMACEUTICALS CPRX 0.86%
IQVIA HOLDINGS INC IQV 0.81%
THERMO FISHER SCIENTIFIC TMO 0.81%
PRAXIS PRECISION MEDICINE PRAX 0.76%
CAREDX INC CDNA 0.74%
AGILENT TECHNOLOGIES INC A 0.68%
DANAHER CORP DHR 0.63%
HINGE HEALTH INC-A HNGE 0.59%
QIAGEN N.V. — 0.51%
ULTRAGENYX PHARMACEUTICAL RARE 0.48%
SAMSUNG EPISHOLDINGS CO L 0126Z0 0.45%
ARCUTIS BIOTHERAPEUTICS I ARQT 0.39%
RHYTHM PHARMACEUTICALS IN RYTM 0.37%
BIO-RAD LABORATORIES-A BIO 0.3%
KINIKSA PHARMACEUTICALS I KNSA 0.29%
BRISTOL-MYERS SQUIBB CO BMY 0.27%
TARSUS PHARMACEUTICALS IN TARS 0.27%
BEONE MEDICINES LTD-ADR ONC 0.25%
NEUROGENE INC NGNE 0.22%
FIRST TRACKS BIOTHERAPEUT TRAX 0.2%
GENEDX HOLDINGS CORP WGS 0.13%
WAVE LIFE SCIENCES LTD WVE 0.12%
RECURSION PHARMACEUTICALS RXRX 0.08%
OMNIAB INC - 15.00 EARNOU 2200964 0%
OMNIAB INC - 12.5 EARNOUT 2200963 0%
Net Current Assets — -0.04%
Show more Hide
Other - %

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Other ETF & Funds from this provider

Similar ETF & Funds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} mln
    NAV
    {{ item.expense_ratio }}
    Total Cost Ratio
Registration is required to get access.